BIOMAT Database Logo BIOMAT Database Logo

Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase. 2001

T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
College of Science and Technology, Nihon University, Tokyo, Japan. akihisa@chem.cst.nihon-u.ac.jp

Fifty-five triterpenoids consisting of 19 tetracyclic, 32 pentacyclic, and 4 incompletely cyclized triterpenoids, and 2 sterols, mostly isolated from various plant and fungal materials, were examined for their inhibitory effects on a purified human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. Twenty triterpenoids and one sterol showed inhibitory effects with 50% inhibition concentration (IC50) values less than 5.0 microM. Among these cycloartenol ferulate (IC50 = 2.2 microM), 24-methylenecycloartanol ferulate (1.9 microM), lupenone (2.1 microM), betulin diacetate (1.4 microM), and karounidiol 29-benzoate (2.2 microM) inhibited most effectively. Some of the triterpenoids and sterols may be potential new lead compounds to find still more potent HIV-1 reverse transcriptase inhibitors.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013261 Sterols Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987) Sterol
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Inhibitory effects of antifungal proteins on human immunodeficiency virus type 1 reverse transcriptase, protease and integrase.
January 2002, Life sciences,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase.
April 1995, Chemical & pharmaceutical bulletin,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Human Immunodeficiency Virus type 1 reverse transcriptase.
February 1996, Biological chemistry Hoppe-Seyler,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Human immunodeficiency virus-1 reverse transcriptase heterodimer stability.
September 1994, Protein science : a publication of the Protein Society,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
A xylanase from roots of sanchi ginseng (Panax notoginseng) with inhibitory effects on human immunodeficiency virus-1 reverse transcriptase.
May 2002, Life sciences,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
January 2004, Current topics in medicinal chemistry,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Effects of cation substitutions on reverse transcriptase and on human immunodeficiency virus production.
March 1997, AIDS research and human retroviruses,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
[The inhibitory effects of catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and DNA polymerases].
October 1992, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase.
January 1995, Methods in enzymology,
T Akihisa, and J Ogihara, and J Kato, and K Yasukawa, and M Ukiya, and S Yamanouchi, and K Oishi
Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous.
January 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Copied contents to your clipboard!